Skip to search formSkip to main contentSkip to account menu

Diclofenac Topical Gel [Solaraze]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: Melanoma and squamous cell carcinoma of the skin are characterized by an altered glucose metabolism, but little is… 
Review
2003
Review
2003
SummaryAbstractTopical 3% diclofenac in 2.5% hyaluronic acid (HA) gel (diclofenac HA gel; Solaraze™1) is an NSAID approved for… 
Review
2003
Review
2003
Actinic keratoses are hyperkeratotic skin lesions that represent focal abnormal proliferation of epidermal keratinocytes. The… 
2003
2003
Topical 3% diclofenac in 2.5% hyaluronic acid (HA) gel (diclofenac HA gel; Solaraze™) is an NSAID approved for the treatment of…